These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3761541)

  • 41. [Pharmacokinetic and clinical studies on cefodizime in the pediatric field. Pediatric Study Group of Cefodizime].
    Fujii R; Arimasu O; Meguro H; Hiruma F; Sugie N; Abe T; Nakazawa S; Sato H; Narita A; Matsumoto K
    Jpn J Antibiot; 1989 May; 42(5):1173-93. PubMed ID: 2664256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of oral cefixime therapy in common infectious diseases in children.
    Lee PI; Lee CY; Chen JM; Huang LM; Hwang KC; Lee MJ
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1991; 32(3):145-50. PubMed ID: 1776438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pharmacokinetic studies on oral antibiotics in pediatrics. I. A pharmacokinetic study on cefixime in pediatrics].
    Nakamura H; Iwai N
    Jpn J Antibiot; 1991 Sep; 44(9):964-78. PubMed ID: 1960858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmacokinetics and clinical evaluation of ceftizoxime (author's transl)].
    Shimizu S; Nobori T; Kawamura Y; Kamiya H; Sakurai M; Izawa T
    Jpn J Antibiot; 1982 Jan; 35(1):171-83. PubMed ID: 6279908
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cefixime in the treatment of lower respiratory tract infections in patients with chronic bronchitis].
    Marcos Sánchez F; Reinoso Cobo D; García Camba L; Celdrán Gil JL
    An Med Interna; 1995 Mar; 12(3):150-1. PubMed ID: 7795125
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical studies with cefmenoxime in the field of pediatrics].
    Takimoto M; Yoshioka H; Maruyama S; Sanae N; Nagamatsu I
    Jpn J Antibiot; 1982 Oct; 35(10):2379-83. PubMed ID: 6306289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical experience of amikacin treatment in infantile bacterial infections (author's transl)].
    Chiba S
    Jpn J Antibiot; 1974 Jun; 27(3):389-91. PubMed ID: 4436952
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of urinary tract infection with cefixime].
    Fujisawa M; Sasaki M; Fujii H; Okamura K; Miyata M; Hashimoto H; Yachiku S; Yamauchi K; Yamaguchi S; Inagaki N
    Hinyokika Kiyo; 1989 Nov; 35(11):1989-92. PubMed ID: 2694832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical role of Cefixime in community-acquired infections.
    Dreshaj Sh; Doda-Ejupi T; Tolaj IQ; Mustafa A; Kabashi S; Shala N; Geca Nj; Aliu A; Daka A; Basha N
    Prilozi; 2011; 32(2):143-55. PubMed ID: 22286619
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Laboratory and clinical studies of cefmenoxime in pediatric infections].
    Miyachi Y; Nakashima T; Aso K; Nishikawa K; Ogawa A; Yafuso M; Kuno K
    Jpn J Antibiot; 1982 Oct; 35(10):2459-67. PubMed ID: 6306297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Fundamental and clinical studies of ceftizoxime rectal suppositories in the field of pediatrics].
    Nakazawa S; Sato H; Narita A; Suzuki H; Nakazawa S; Chikaoka H; Tazoe K; Oka S; Nakada Y
    Jpn J Antibiot; 1985 Oct; 38(10):2863-76. PubMed ID: 3866081
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical and pharmacokinetic evaluation of cefodizime in children].
    Hirabayashi Y; Higashino H; Kino M; Nobori U; Okazaki H; Kitamura N; Kobayashi Y
    Jpn J Antibiot; 1989 Jun; 42(6):1366-80. PubMed ID: 2795860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and efficacy of cefixime in treatment of respiratory tract infections in Germany.
    Hausen T; Weidlich G; Schmitt J
    Infection; 1995; 23 Suppl 2():S65-9. PubMed ID: 8537134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Basic and clinical studies on cefmenoxime in pediatric field].
    Aoyama R; Kakizaki Y; Ohnishi A; Izumi Y; Nagata K; Fujita M; Asuka N; Kudo M; Matsumura C; Chiba C; Takahashi Y; Tsushima N; Okamoto T; Kuronuma T; Haneda S
    Jpn J Antibiot; 1982 Oct; 35(10):2384-92. PubMed ID: 6306290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A review of the safety profile of cefixime.
    Wu DH
    Clin Ther; 1993; 15(6):1108-19. PubMed ID: 8111808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study on cefodizime, a new cephem antibiotic, in the field of pediatrics].
    Sato H; Narita A; Matsumoto K; Nakazawa S; Suzuki H; Nakanishi Y; Niino K; Nakazawa S
    Jpn J Antibiot; 1989 Jun; 42(6):1306-21. PubMed ID: 2795855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparative study of cefixime versus amoxicillin-clavulanic acid combination in the oral treatment of urinary tract infections in children].
    François P; Croizé J; Bost C; Wollschlager K
    Arch Pediatr; 1995 Feb; 2(2):136-42. PubMed ID: 7735445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Efficacy and tolerability of cefixime in urinary tract infections in adults. A French multicentric study].
    Modai J
    Presse Med; 1989 Oct; 18(32):1614-6. PubMed ID: 2530545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of cefotaxime in bacterial infections.
    Varghese M; Khan AJ; Kumar K; Schaeffer HA; Pierro M; Evans HE
    Clin Pediatr (Phila); 1984 Apr; 23(4):220-2. PubMed ID: 6321080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical studies on cefprozil in pediatrics].
    Sekiguchi T; Shiino Y; Murakawa K; Nishimori M; Kouzan H; Ohara K; Okamoto T
    Jpn J Antibiot; 1992 Dec; 45(12):1650-7. PubMed ID: 1289583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.